BRPI0513856A - uso de um composto peptìdico - Google Patents
uso de um composto peptìdicoInfo
- Publication number
- BRPI0513856A BRPI0513856A BRPI0513856-6A BRPI0513856A BRPI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A BR PI0513856 A BRPI0513856 A BR PI0513856A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- peptide compound
- toxins
- peptide
- bacterial
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 231100000699 Bacterial toxin Toxicity 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000000688 bacterial toxin Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002158 endotoxin Substances 0.000 abstract 1
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04077175A EP1621205A1 (en) | 2004-07-28 | 2004-07-28 | Antimicrobial peptides derived from CAP18 |
| PCT/NL2005/000545 WO2006011792A2 (en) | 2004-07-28 | 2005-07-26 | Antimicrobial peptides derived from cap18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0513856A true BRPI0513856A (pt) | 2008-05-20 |
Family
ID=34928414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0513856-6A BRPI0513856A (pt) | 2004-07-28 | 2005-07-26 | uso de um composto peptìdico |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7803756B2 (enExample) |
| EP (3) | EP1621205A1 (enExample) |
| JP (1) | JP2008508265A (enExample) |
| KR (1) | KR20070050941A (enExample) |
| CN (1) | CN101018563A (enExample) |
| AU (1) | AU2005267651B2 (enExample) |
| BR (1) | BRPI0513856A (enExample) |
| CA (1) | CA2574959A1 (enExample) |
| NZ (1) | NZ553175A (enExample) |
| RU (1) | RU2392962C2 (enExample) |
| WO (1) | WO2006011792A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
| EP2099466B1 (en) | 2006-12-01 | 2015-06-03 | Laclede, Inc. | Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| KR20100056479A (ko) | 2007-07-25 | 2010-05-27 | 바이오렉스 쎄라퓨틱스, 인코포레이티드 | 제어 방출 인터페론 약물 제품 및 이를 사용한 ｈｃｖ 감염의 치료 |
| US20100184684A1 (en) * | 2009-01-06 | 2010-07-22 | C3 Jian, Inc. | Antibacterial and antifungal peptides |
| EP3252068B1 (en) | 2009-10-12 | 2025-07-02 | Larry J. Smith | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| RU2434880C1 (ru) * | 2010-07-21 | 2011-11-27 | Общество С Ограниченной Ответственностью "Биохарт" | Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека |
| RU2646102C2 (ru) * | 2012-05-09 | 2018-03-01 | Контрафект Корпорейшн | Предотвращение, разрушение и обработка биопленки лизином бактериофага |
| PL2994154T3 (pl) * | 2013-05-10 | 2020-07-27 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Peptyd antydrobnoustrojowy |
| US9387189B2 (en) | 2013-05-22 | 2016-07-12 | Professional Compounding Centers Of America (Pcca) | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion |
| WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| BR112016013600A2 (pt) * | 2013-12-12 | 2017-10-03 | Academisch Ziekenhuis Leiden | Peptídeo antimicrobiano e seus usos |
| WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
| WO2023049162A1 (en) * | 2021-09-21 | 2023-03-30 | Biomedit, Llc | Antimicrobial peptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4037525B2 (ja) * | 1998-03-25 | 2008-01-23 | 生化学工業株式会社 | 新規抗菌性ペプチド |
| EP1587830B1 (en) * | 2003-01-28 | 2009-07-08 | Academisch Ziekenhuis Leiden | Peptide inhibitors of toxins derived from ll-37 |
| US7718618B2 (en) * | 2003-10-21 | 2010-05-18 | The Regents Of The University Of California | Human cathelicidin antimicrobial peptides |
| EP1621205A1 (en) * | 2004-07-28 | 2006-02-01 | OctoPlus Technologies B.V. | Antimicrobial peptides derived from CAP18 |
-
2004
- 2004-07-28 EP EP04077175A patent/EP1621205A1/en not_active Withdrawn
-
2005
- 2005-07-26 BR BRPI0513856-6A patent/BRPI0513856A/pt not_active IP Right Cessation
- 2005-07-26 NZ NZ553175A patent/NZ553175A/en unknown
- 2005-07-26 CA CA002574959A patent/CA2574959A1/en not_active Abandoned
- 2005-07-26 WO PCT/NL2005/000545 patent/WO2006011792A2/en not_active Ceased
- 2005-07-26 JP JP2007523501A patent/JP2008508265A/ja active Pending
- 2005-07-26 AU AU2005267651A patent/AU2005267651B2/en not_active Ceased
- 2005-07-26 CN CNA2005800255122A patent/CN101018563A/zh active Pending
- 2005-07-26 RU RU2007107390/15A patent/RU2392962C2/ru not_active IP Right Cessation
- 2005-07-26 EP EP09158381A patent/EP2221061A1/en not_active Withdrawn
- 2005-07-26 EP EP05769152A patent/EP1784206A2/en not_active Withdrawn
- 2005-07-26 US US11/658,415 patent/US7803756B2/en not_active Expired - Fee Related
- 2005-07-26 KR KR1020077004988A patent/KR20070050941A/ko not_active Withdrawn
-
2010
- 2010-09-14 US US12/882,089 patent/US20110053835A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1621205A1 (en) | 2006-02-01 |
| WO2006011792A3 (en) | 2006-09-14 |
| US20080249022A1 (en) | 2008-10-09 |
| RU2007107390A (ru) | 2008-09-10 |
| JP2008508265A (ja) | 2008-03-21 |
| KR20070050941A (ko) | 2007-05-16 |
| US20110053835A1 (en) | 2011-03-03 |
| RU2392962C2 (ru) | 2010-06-27 |
| US7803756B2 (en) | 2010-09-28 |
| AU2005267651A1 (en) | 2006-02-02 |
| AU2005267651B2 (en) | 2010-05-27 |
| CN101018563A (zh) | 2007-08-15 |
| NZ553175A (en) | 2009-10-30 |
| EP1784206A2 (en) | 2007-05-16 |
| EP2221061A1 (en) | 2010-08-25 |
| CA2574959A1 (en) | 2006-02-02 |
| WO2006011792A2 (en) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513856A (pt) | uso de um composto peptìdico | |
| BRPI0510428A (pt) | composições tópicas de metadona e processos para utilização das mesmas | |
| BRPI0810064B8 (pt) | compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos | |
| BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
| MY150958A (en) | Compounds for the treatment of multi-drug resistant bacterial infections | |
| BRPI0411016A (pt) | composições antisépticas, processos e sistemas | |
| BR0317564A (pt) | Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos | |
| BRPI0821110B8 (pt) | anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
| NZ597046A (en) | Use of alpha-toxin for treating and preventing staphylococcus infections | |
| NO20076675L (no) | Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet | |
| CL2004000930A1 (es) | Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos. | |
| MX2020011873A (es) | Nuevos derivados de quinolina. | |
| BRPI0612125A2 (pt) | compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos | |
| BRPI0516077A (pt) | composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes | |
| BR0309757A (pt) | 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases | |
| BRPI0617655A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica | |
| BRPI0414139A (pt) | métodos e composições para tratar infecções por herpes | |
| UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
| BR112013024909A2 (pt) | composto, composição farmacêutica, método para o tratamento, prevenção ou melhoria de um ou mais sintomas de desordem, doença, ou condição mediada por pi3k, e método para modular a atividade enzimática de pi3k | |
| BRPI0613999B8 (pt) | uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto | |
| BRPI0514892A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| DE60217292D1 (de) | Veterinärmedizinische dermatologische zusammensetzung | |
| BRPI0515555A (pt) | composição farmacêutica compreendendo éster de temozolomida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |